Transform Wealth, LLC Eli Lilly & CO Transaction History

Transform Wealth, LLC

$1.46 Billion
Q3 2024

A detailed history of Transform Wealth, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Transform Wealth, LLC holds 5,071 shares of LLY stock, worth $4.03 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

5,071

Previous 5,262 3.63%

Holding current value

$4.03 Million

Previous $4.76 Million 5.71%

% of portfolio

0.31%

Previous 0.36%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$772.14 - $960.02 $147,478 - $183,363	-191 Reduced 3.63%	5,071 $4.49 Million
Q2 2024 Jul 15, 2024	SELL	$724.87 - $909.04 $92,058 - $115,448	-127 Reduced 2.36%	5,262 $4.76 Million
Q1 2024 Apr 15, 2024	SELL	$592.2 - $792.28 $2.4 Million - $3.21 Million	-4,050 Reduced 42.91%	5,389 $4.19 Million
Q4 2023 Jan 18, 2024	SELL	$525.19 - $619.13 $805,116 - $949,126	-1,533 Reduced 13.97%	9,439 $5.5 Million
Q3 2023 Oct 10, 2023	SELL	$434.7 - $599.3 $5.08 Million - $7 Million	-11,679 Reduced 51.56%	10,972 $5.89 Million
Q2 2023 Jul 13, 2023	SELL	$350.74 - $468.98 $1.96 Million - $2.62 Million	-5,580 Reduced 19.77%	22,651 $10.6 Million
Q1 2023 Apr 14, 2023	BUY	$310.63 - $364.82 $4.38 Million - $5.15 Million	14,109 Added 99.91%	28,231 $9.7 Million
Q4 2022 Jan 12, 2023	BUY	$321.55 - $374.67 $4.54 Million - $5.29 Million	14,122 New	14,122 $0
Q1 2018 May 03, 2018	SELL	$74.21 - $87.6 $2.07 Million - $2.44 Million	-27,882 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$81.94 - $87.89 $98,000 - $105,116	1,196 Added 4.48%	27,882 $2.36 Million
Q3 2017 Oct 19, 2017	BUY	$77.07 - $85.54 $2.06 Million - $2.28 Million	26,686	26,686 $2.28 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Transform Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transform Wealth, LLC with notifications on news.

Account

Transform Wealth, LLC Eli Lilly & CO Transaction History